|
Japan » Business Opportunities » R & D Collaborations ::
(1) Development :
Torrent can be your partner of choice for,
| › |
Generic Drugs |
| › |
Registration dossiers + product supply of attractive products/ developed or under various stages of development |
| › |
APIs |
| › |
Chemical synthesis, Process development, DMFs |
| › |
Custom Synthesis |
| › |
R&D centre well equipped for development and implementation of new processes, process scale-up and transfer to plant-scale productions |
(2) Discovery :
Torrent is constantly and proactively seeking human health opportunities for New Chemical Entities (NCE's) as product candidates for development, where there are unmet medical needs and where new or better treatments are needed.
Early research collaborations potentially leading to an NCE as well as platform research technologies and research tools are also part of our collaboration strategy. Our major research areas including the following:
| › |
Metabolic Disorders |
| › |
Cardiovascular Disorders |
| › |
Cerebrovascular Disorders |
As Torrent is actively engaged in advanced pre-clinical studies leading to phase I clinical trials and eventual proof of concept in man, we are open to explore partnership opportunities for following two programs.
| › |
AGE Breaker
AGE (Advanced Glycosylation End-products) breaker compound in advanced pre-clinical stage have potential in correcting diabetic complications like neuropathy, nephropathy, retinopathy and heart failure.
|
| › |
DPP-IV Inhibitors
Agents meant for treatment of type II diabetes. Torrent’s Dipeptidyl peptidase-IV (DPP-IV) inhibitor in advanced pre-clinical stage is able to increase insulin output and maintain better glucose tolerance in insulin resistant models even when they enter the phase of severe diabetes. |
(3) Contact Us :
For Business Queries Please Contact,
Dr. Chaitanya Dutt
Director, Research and Development
Torrent Research Centre
P.O. Bhat
Dist.- Gandhinagar
Dist.- Gandhinagar
Gujarat, India.
E-mail cdutt@torrentpharma.com
Mr. Toshimitsu Kurogi
Representative Director
Torrent Pharma Japan Co. Ltd.
SOHO STATION 1003
24-8 Yamashita-cho, Naka-ku
Yokohama, 231-0023,
JAPAN.
|
